Profil
Rachel Belsham is currently working as an Operating Advisor at Revival Healthcare Capital LLC.
Prior to this, she worked as an Executive Vice President-Strategic Development at Visa Europe Ltd. She completed her undergraduate degree from the University of Oxford in 1989.
Aktive Positionen von Rachel Belsham
| Unternehmen | Position | Beginn |
|---|---|---|
Revival Healthcare Capital LLC
Revival Healthcare Capital LLC Investment ManagersFinance Revival Healthcare Capital invests in companies located in the United States with an enterprise value of USD 150 million - 1 billion and revenue of USD 10 - 500 million. The firm targets companies operating in the fields of healthcare, technology, medical devices and diagnostics sectors. It provides financing for buyout, recapitalization and growth stage capital requirements with an investment size of USD 10 - 250 million. The firm acquires majority, minority and controlling interest and makes co-investments. It also acts as a lead investor. | Berater | - |
Ehemalige bekannte Positionen von Rachel Belsham
| Unternehmen | Position | Ende |
|---|---|---|
Visa Europe Ltd.
Visa Europe Ltd. Regional BanksFinance Operates digital payments network and issues credit and debit cards | Corporate Officer/Principal | - |
Ausbildung von Rachel Belsham
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Visa Europe Ltd.
Visa Europe Ltd. Regional BanksFinance Operates digital payments network and issues credit and debit cards | Finance |
University of Oxford
University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Revival Healthcare Capital LLC
Revival Healthcare Capital LLC Investment ManagersFinance Revival Healthcare Capital invests in companies located in the United States with an enterprise value of USD 150 million - 1 billion and revenue of USD 10 - 500 million. The firm targets companies operating in the fields of healthcare, technology, medical devices and diagnostics sectors. It provides financing for buyout, recapitalization and growth stage capital requirements with an investment size of USD 10 - 250 million. The firm acquires majority, minority and controlling interest and makes co-investments. It also acts as a lead investor. | Finance |
















